Member Info for dactions

We can't be sure Jay1987 when the quarterly report will be published. But I feel there's every chance we'll learn how the 2nd quarter has gone perhaps as early as this week - if not then next Monday.

By the way, I'm very optimistic that the announcement will be pleasing for shareholders.

I really appreciate the efforts of fellow investors keeping us informed on this Board about our shareholding in Synairgen. In the past I've attended similar AGM's and reported back but can't get to these early meetings any more . So, am all the more grateful to Doc83 and Wigster for their time and efforts. Thank you.

Yes maninpink - AGM is indeed tomorrow.

I was re-looking at the 6th June investor statement and presumably referring to 31/12/2021 one of their highlights listed was: "Over 30,000 new direct customers" and Penny McCormick, CEO said in her statement:
"Whilst we did deliberately delay the launch of the wider portfolio of wellness products until the COVID market stabilised, we have in the meantime demonstrated our ability to effectively identify the right tests for the market, secure supplier and customer relationships, and manage challenging supply chains effectively, whilst remaining competitive on price, and excelling in customer service and delivery.
We have in place a secure digital platform, a customer base opening up to the new idea of home-testing, and an existing
customer base to whom we can share our new product information.
2022 will be another exciting year for the business as we launch our initial portfolio of new tests and build upon our
sophisticated digital platform, which presents a fantastic opportunity for us to grow and create value for our
shareholders. This will be supported by positive trading in the COVID space, as over the counter consumer demand
continues into 2022. "

So, these are fine words but what exactly do they mean when it comes to action ? They have a wonderfully large customer database - have they started selectively emailing some of them ? I hope we learn more tomorrow although they've not really been that communicative to date vis a vis other AIM companies.

Clued - you've been an LSE member long enough to know no one can honestly answer your question "Case in favour of investing here". We're all chasing big share price uplifts when it comes to the Aim market but the negative is that this market is full of Companies giving scant information to shareholders once they've received the initial funds.

There is though one big factor in favour of Woodbois and that is their discipline in regular and timely updates. We can expect news of 2nd quarter results by mid July if not earlier. Here's what I wrote recently:
"As for WoodBois, we can expect early next month news of 2nd quarter trading. I'm confident that the excellent momentum we've seen from WBI these past 12 months will continue. What's not to like ? Even Gabon, a Francophone country, has applied to join the Commonwealth !"

All the best.

"Brad you no longer have shares in woodbois .. so why are you continuing to post on here ? Not only posting, but posting to try and put people off investing in woodbois ? That’s a pretty low thing to do isn’t it ?"

Bradsmith - I've quoted above the point Jay1987 made and I think he is right. I did extensive google searches and the ramping article of Ronald Brown is no longer being touted as it had been many weeks ago by paid-for google ad placements. I gave you the link to new companies that are being touted - there is NO mention of WoodBois.

I've enjoyed some of your past comments but as you've told us yourself, you are now a confirmed ex-shareholder, so it's not fair to fly stories that are no longer relevant.

Does anyone have any info as to whether FUM made any additional comments ? My main concern is that despite all the supposedly 'wonderful' contracts to supply eroxon around the world, this past 18 months, there is still no sign of any product !

"Even Gabon, a Francophile country, has applied to join the Commonwealth "

Francophile - I meant Francophone of course.

Thanks Palmsairport - must be the first review for Myhealthchecked and I agree with others it looks genuine.

But I still wonder how they're going to grow this 'wellness' market. I've spent a lot of time googling this word/that phrase and can't get mhc to come up in any page ranking out to 10 pages. There's a lot of paid placement ads of course but even so, businesses like letsgetchecked.com comes up well in first or early pages. They've been going a long time of course and perhaps it's still too early to expect mhc to rank even with their excellent website editorial - a key Google rank identifier.

Am I being impatient or perhaps mhc is only slowly stepping into this market ? As someone who registered an account with mhc, I'm surprised my email hasn't received any marketing ? Perhaps this is because I haven't yet bought anything from the company but it leaves me feeling puzzled how this new business is going to grow dynamically.

Bradsmith - I think you're wrong to be highlighting this right now as it's a 'non-story' as far as WoodBois is concerned. The rampers have moved on and are promoting other shares now:
For example put in google 'best shares for carbon credits' and you'll typically get a link like this:
https://www.dgb.earth/carbon-offset-blog/carbon-green-stocks.

As for WoodBois, we can expect early next month news of 2nd quarter trading. I'm confident that the excellent momentum we've seen from WBI these past 12 months will continue. What's not to like ? Even Gabon, a Francophile country, has applied to join the Commonwealth !

I've known all the time !!
It's the exclamation marks - gives the game away !!!

With the sp at the current low-level it doesn't take much of an increase to look a high percentage. Unless there has been a large Buy yet to be shown, I doubt on today's modest deals, all we're seeing is the MMs trying to stimulate a market in the shares.

OneJagielka - I think we have to agree his concerns - I know I'm becoming very negative with all my recent posts and am concerned where this share is going. I know it's early days for the new products, but have you noticed how few TrustPilot reviews are now being uploaded each day ? I guess it's too early for a 'Wellness' one.

The other thing is, I registered myself for an account on their mailing list but haven't seen any company messages - so I ask myself how are 'Wellness' sales going to happen online if there's no marketing ?

I'm adding this post in the hope someone at MHC might read it.

"One product looks like you have a problem downstairs and have a medicine for it. The other product looks like your secret super weapon to enhance your performance. Which do you think will get more sales???"

Fuzzbox - how right you are with your two examples - ours is rather like selling a medical device: a crutch or a high seated loo - whereas a hint of 'spanish fly' wouldn't go amiss.

With today's RNS, the prospects are looking even worse than I thought they would be when I sold out at 5.5p just prior to the management changes. I'm sorry for those that have stayed with what was once a substantial group.

But with the new Board blaming the Maritime section, is this a ruse to lead the sp even lower so the largest holder can pick up the company on the cheap ?

There was a substantial trade reported this afternoon from last Friday at 5.8p. I am away from last week's indices and wondered if anyone else can tell what the trading prices were at 15:24 ?

17-Jun-22 15:24:24 5.80 4,000,000 Unknown* 5.60 5.80 232.00k

This guy is just a troll. It has appeared in just the last weeks trashing the company - IGNORE

As for the Motley Fool articles - they all say the same that WoodBois shows great promise but it doesn't suit their portfolio. They all similar in pattern but all by supposedly different authors. What's their purpose you ask ? I think it's an easy write-up for a share such as WBI that has a lot of watchers. Motley Fool used to have some investment merit but all they're trying to do is entice one into subscribing into their share tips - AVOID

There has been some really thoughtful responses on this thread with regard to the new products - I'd like to think someone at MHC might see some of them - I haven't seen any marketing or advertising as yet - has anyone ?

There's a grammatical error on the bottom of all the product pages: "This test is not a diagnostic or medical device. This test is focuses on genetic indicators that are linked to wellness advice." The error being either the 'is' is out or focuses becomes 'focused'. I've relayed that to MHC.

cuvio - re what MHC product does and whether it's sufficiently different (or better) than say for example Randox's cheaper product, will require independent and authoritative analysis - that's going to be hard to get.

We need the feature pages of the weekend papers to get that message across - even then it's no easy task.

I do think too many of us look at Polygon as our saviour when the truth is they've been blind-sided as the rest of us were. The good thing though is that they do hold a substantial holding and thus will be in a position to influence decisions that will regain some if not all of the value thy invested.

The other good thing is that their average is higher than mine - at least I got one thing right ;-)

GLA

Don't disagree with the good looking, clean, simple image of the new website - but - on the other hand, this is what MHC is up against and we are going to have to be very slick to build sales in my opinion. I really hope the Board appreciate as I'm quite sure that with these wide spreads in MHC shares, just about all of us must be well under water with our holdings, big or small.

https://www.randoxhealth.com/heart-health